Related Experiment Video
Updated: Sep 14, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Global epidemiology of type 1 diabetes in youth: 1990-2021 and projections to 2045
Kexin Zhang1, Chengxia Kan1, Fang Han2
1Department of Endocrinology and Metabolism, Clinical Research Center, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Aims:
This study examines the global burden of type 1 diabetes (T1D) among adolescents and young adults (15-39 years) from 1990-2021, with projections to 2045.
Methods:
Using data from the Global Burden of Disease (GBD) 2021, we analyzed T1D prevalence, incidence, deaths, disability-adjusted life years (DALYs), and annual percent change (AAPC), with regional and gender differences.
Results:
In 2021, global T1D prevalence among 15-39-year-olds was 7.34 million cases (95% UI: 5.94-9.00 million), with males accounting for 50.66%. Incidence was 196,104 cases (141,606-277,782), with 55.31% males. From 1990-2021, prevalence increased from 200.11-246.89 per 100,000 (AAPC 0.68), and incidence rose from 5.10-6.59 per 100,000 (AAPC 0.83). In 2021, there were 16,135 deaths and 1.40 million DALYs, with 54.94% attributed to males. Death rates decreased (AAPC -0.35). Middle SDI regions had the highest prevalence (1.86 million) and incidence (54,541), while high SDI areas had the highest rates. Low-middle SDI areas had the most deaths (5170) and DALYs (419,772). South Asia had the highest prevalence (1.73 million), incidence (46,310), deaths (5189), and DALYs (413,293). India, the USA, and China had the highest prevalence and incidence, while Finland, Canada, and Italy had the highest rates. By 2045, T1D incidence is projected to reach 571,556 cases, predominantly affecting those aged 15-19 years.
Conclusion:
The rising burden of T1D among adolescents and young adults underscores the need for targeted interventions and healthcare policies, particularly in high-risk regions.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

